Analysis of biologically active stilbene derivatives

Critical Reviews in Analytical Chemistry

Volumn 39, Issue 2, 2009, Pages 70-80

  Chrzaścik, Ireneusz ^a  

^a SIEDLCE UNIVERSITY OF NATURAL SCIENCES AND HUMANITIES   (Poland)

Author keywords

(E) azastilbenes; Biological properties; Capillary electrophoresis; Chromatography; Determination

Indexed keywords

(E)-AZASTILBENES; BIOLOGICAL ACTIVITIES; BIOLOGICAL PROPERTIES; DETERMINATION; INFORMATION CONCERNING;

CAPILLARY ELECTROPHORESIS; CARDIOVASCULAR SYSTEM; CHROMATOGRAPHIC ANALYSIS; CHROMATOGRAPHY; LIQUID CRYSTALS;

ELECTROCHEMISTRY;

ANTIMICROBIAL ACTIVITY; BIOACTIVITY; BIOCHEMISTRY; CHEMOSYNTHESIS; COMPLEXATION; DRUG; ELECTROKINESIS; LIQUID CHROMATOGRAPHY;

EID: 70350224176     PISSN: 10408347     EISSN: 15476510     Source Type: Journal    
DOI: 10.1080/15389580802570184     Document Type: Article

References (60)

1. B. Yin, F. Niemeyer, J. A. Gareth, W. Ji Jiang, A. Boucekkine, L. Toupet, H. Le Bozec, and V. Guerchais, Synthesis, structure, and photophysical properties of luminescent platinum (II) complexes containing cyclometalated 4-styrylfunctionalized 2-phenylpyridine ligands. Inorganic Chemistry 45 (2006):8584-8596.
2. M. Hutta, D. Kaniansky, E. Śimuniéova, V. Zelenska, V. Madajova, and A. Śiśkova, Solid phase extraction for sample preparation trace analysis of ionogenic compounds by capillary isotachophoresis. Journal of Radioanalytical and Nuclear Chemistry 1, 163 (1992):87-98.
3. F. M. Everaerts, J. Beckers, and L. Verheggen, Isotachophoresis. Theory, instrumentation and applications. Journal of Chromatography Library (JournalSeek) 6 (1976):418-428.
4. J. Østergaard, Application of retention factors in affinity electrokinetic chromatography and capillary electrophoresis. Analytical Sciences 23 (2007):489-492.
5. E. Wyrzykiewicz, W. Prukała, and B. ķedzia, Synthesis and antimicrobial properties of N-substituted derivatives of (E)-alpha-(or gamma)-azastilbenols. Ill Farmaco 49 (1994):127-131.
6. B. R. Baker and R. E. Gibson, Irreversible enzymne inhibitors. Inhibition of choline acetyltrasferase. Mode of binding by 4- stilbazoles. Journal of Medicinal Chemistry 15, 6 (1972):639-648.
7. V. Bangani, N. R. Crouch, and D. A. Mulholland, Homoisoflavanoes and stilbenoids from Scilla nervosa. Phytochemistry 51 (1999):947-951.
8. O. Daniel, M. S. Meier, J. Schlatter, and P. Frischhnecht, Selected phenolic compounds in cultivated plants: Ecologic functions, health implications, and modulation by pesticides. Environmental Health Perspectives 107 (1999):109-114.
9. J. Bais, P. J. Murphy, and I. B. Dry, The molecular regulation of stilbene phytoalexin biosynthesis in Vitis vinifers during grape berry development. Australian Journal of Plant Physiology 27 (2000):425-433.
10. J. D. Hipskind and N. L. Paiva, Constitutive accumulation of a resveratrol-glucoside in transgenic alfaincrases resistance to Phoma medicaginis. Molecular Plant-Microbe Interactions 13 (2000):551-562.
11. E. Wyrzykiewicz and W. Prukała, Synthesis and antimicrobial properties of N-substituted halides of (E)-azastilbenols. Il Farmaco 50 (1995):779-782.
12. W. Prukała and B. Kedzia, Antimicrobial activity of some Nalkyl and N-nitrobenzyl substituted halides of (E)-4_-hydroxy-3_- methoxystilbazoles-4. Il Farmaco 54 (1999):584-587.
13. M. Takagi, T. Honmura, S. Watanabe, R. Yamaguchi, M. Nogawa, I. Nishimura, F. Katoh, M. Matsuda, and H. Hidaka, In vivo antitumor activity of a novel sulfonamide HMN-214, against human tumor xenografts in miceand the spectrum of cytotoxicity of its active metabolite HMN-176. Investigational New Drugs 21 (2003):387-399.
14. S. Kim, S.Y. Min, S. K. Lee and W. J. Cho, Comparative molecular field analysis study of stilbene derivatives active against A549 lung carcinoma. Chemical&Pharmaceutical Bulletin 51,5 (2003):516-521.
15. A. Bertelli, L. Giovannini, D. Z. Giannessi, M. Migliori, W. Bernini, M. Fregoni, and A. Bertelli, Anti-platelet activity of synthetic and natural resveratrol in red wine. International Journal of Tissue Reaction 17 (1995):1-3.
16. A. Bertelli, L. Giovannini, W. Bernini, M. Migliori, M. Fregoni, L. Baveresco and A. Bertelli, Anti-platelet activity of cis-resveratrol. Drugs Under Experimental and Clinical Research (Geneva) 22 (1996):61-63.
17. T. A. Aburjai, Anti-platelet stilbenes from aerial parts of Rheum palaestinum. Phytochemistry 55 (2000):407-410.
18. L. M. Hung, J. K. Chen, S. S. Huang, R. S. Lee, and M. J. Su, Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovascular Research - Elsevier 47 (2000):549-555.
19. G. O. Armstrong, M. G. Lamberchts, E. P. G. Mansvelt, D. P. Van Velden, and J. S. Pretorius,Wine and health. South African Journal of Marine Science 97 (2001):279-282.
20. M. I. Chung, C. M. Teng, K. L. Cheng, and F. N. Ko, An antiplatelet principle of Veratrum Formosanum. Planta Medice 58 (1992):274-276.
21. S. Kobayashi, C. K. Ding, Y. Nakamura, I. Nakajima, and R. Matsumoto, Kiwifruits (actinida deliciosa) transfered with a Vitis stilbene synthase gene produce piceid (resveratrol-glukoside). Plant Cell Reports 19 (2000):904-910.
22. R. Pace-Asciak, S. Hahn, E. P. Diamandis, G. Soleas, and D. M. Goldberg, The red wine phenolics, trans-resveratrol and quercetin block human platelet aggregation and eicosanoids synthesis: Implication for protection against coronary heart disease. Clinica Chimica Acta 23 (1995):207-219.
23. A. Olas, B. Wachowicz, J. Saluk-Juszczak, J. Szewczuk, and W. Kaca, The effect of resveratrol on the platelet secretory process induced by endotoxin and thrombin. Microbios 105 (2001):7-13.
24. M. H. Azizi, R. Kumar, and N. Ahmad, Cancer chemoprevention by resveratrol: In vitro and in vivo studies and the underlying mechanisms (Review). International Journal of Oncology 23 (2003):17-28.
25. J. Burns, P. Gardner and T. O'Neal, Relationship among antioxidant activity, vasodilatation capacity, and phenolics content of red wines. Journal of Agricultural and Food Chemistry 48 (2000):220-230.
26. S. Yehuda, S. Rabinovitz, and D. I. Mostofsky, Essential fatty acids are mediators of brain biochemistry and cognitive functions. Journal of Neuroscience Research 56 (1999):565-570.
27. J. Martinez and J. J. Moreno, Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochemical Pharmacology - Elsevier 59 (2000):865-870.
28. B. Olas, H. M. Bikowska, B. Wachowicz, T. Krajewski, A. Buczyński, and A. Magnuszewska, Inhibitory effect of resveratrol on free radical generation in blood platelets. Acta Biochimica Polonica 46 (1999):991-996.
29. B. Olas, B. Wachowicz, J. Saluk-Juszczak, T. Zieliński, W. Kaca, and A. Buczyński, Antioxidant activity of resveratrol in endotoxin stimulated blood platelets. Cell Biol. Toxicol. 17 (2001b):10-19.
30. C. M. A. Nieuwenhouys, A. H. Feijge, R. F. G. Offermans, A. D. M. Kester, and G. Homstra, Modulation of rat platelet activation by vessel wall-derived prostaglandin and platelet-derived thromboxane: Thromboxane-prostaglandin balance. Artherosclerosis 154 (2001):355-366.
31. L. Fremont,Biological effects of resveratrol. Life Science - Elsevier 66 (2000):663-673.
32. N. Frankel, J. Kanner, J. B. German, E. Parks, and J. E. Kinsella, Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. The Lancet 341 (1993):454-457.
33. L. Fremont, L. Belguendouz, and S. Delpal, Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids. Life Science - Elsevier 64 (1999):2511-2521.
34. D. Blache, L. Gesquiere, N. Loreau, and P. Durand, Oxidant stress: The role of nutrients in cell-lipoprotein interactions. The Journal of Nutritional Biochemistry 58 (1999):559-563.
35. B. Halliwell, Lipid peroxidation, antioxidants and cardiovascular disease: How should we move forward. Cardiovascular Research - Elsevier 47 (2000):410-418.
36. T. M. Bray,Dietary antioxidants and assessment of oxidative stress. Nutrition 16 (2000):578-581.
37. M. Mutanen and R. Freese, Fats lipids and blood coagulation. Current Opinion Lipidology 12 (2001):25-29.
38. W. Ducan, J. Bruce, and P. Rourke, The synthesis and characterization of potentially mesomorfic carbonyl complexes of tungsten (0) with substituted pyridines. Polyhedron 14, 13-14 (1995):1915-1922.
39. T. James, C. J. Jones, J. A. McCleverty, D. W. Bruce, and M. G. Hutchings, The synthesis of some paramagnetic stilbazole complexes and an evaluation of their redox and mesogenic properties. Polyhedron 14, 17-18 (1995):2499-2504.
40. Annoni, M. Pizzotti, R. Ugo, S. Quici, T. Morotti, N. Casati and P. Macchi, The effect on E-stilbazoles second order NLO response by axial interaction with M(II) 5,10,15,20-tetraphenyl porphyrinates (M = Zn, Ru, Os); a new crystalline packing with very large holes. Inorganica Chimica Acta 359 (2006):3029-3041.
41. D. M. Huck, H. L. Nguyen, S. J. Coles, M. B. Hursthouse, B. Donnio, and D. W. Bruce, Mesomorfic silver (I) complexes of 4-alkoxy-2_-stilbazoles and 4-alkoxy-3_-stilbazoles. Crystal and molecular structure of 4-methoxy-2_-stilbazole. Journal of Materials Chemistry Articles 12 (2002):2879-2886.
42. J. C. Smith, C. J. Cavallito, and F. F. Foldes, Choline acetyltransferase inhibitors: a group of styrylpyridine analogs. Biochemical Pharmacology 16 (1967):2438.
43. C. J. Cavallito, H. S. Yun, J. C. Smith, and F. F. Foldes, Choline acetyltransferase inhibitors. Configurational and electronic features of styrylpyridine analogs. Journal of Medicinal Chemistry 12 (1969):134-138.
44. C. J. Cavallito, H. S. Yun, T. Kaplan, J. C. Smith, and F. F. Foldes, Choline acetyltransferase inhibitors. Dimensional and substituent effects among styrylpyridine analogs. Journal of Medicinal Chemistry 13 (1970):221-224.
45. Arena, F. Manna, C. Pizza, M. L. Stein and M. Grifantini, Structure-activity relations in reactirators of organophosphorus-inhibited acetylcholinesterase. 10. Hydroxyiminomethylarylethenylpyridine methiodides. Journal of Medicinal Chemistry 18 (1975):1147-1151.
46. B. Buszewski, R. Gadzała-Kopciuch, and M. Jaroniec, Chromatographic properties of mixed chemically bonded phases with alkylamide and aminopropyl ligands. Journal of Liquid Chromatography & Related Technologies 20 (1997):2313-2325.
47. B. Buszewski, R. Gadzala-Kopciuch, M. Markuszewski, and R. Kaliszan, Chemically bonded silica stationary phases: Synthesis, physicochemical characterization, and molecular mechanism of reversed-phase HPLC retention. Analytical Chemistry 69 (1997):3277-3284.
48. B. Buszewski, R. Gadzała-Kopciuch, R. Kaliszan, M. Markuszewski, M. T. Matyska, and J. J. Pesek, Polyfunctional chemically bonded stationary phases for reversed phase high performance liquid chromatography. Chromatographia 48 (1998):615-622.
49. B. Buszewski, K. Krupczyńska, R. Gadzała-Kopciuch, G. Rychlicki and R. Kaliszan, Evaluation of HPLC columns: A study on surface homogeneity of chemically bonded stationary phases. Journal of Separation Science 26 (2003):313-321.
50. R. Gadzała-Kopciuch, M. Kluska, M. Wełniak and B. Buszewski, Silicon dioxide surfaces with aryl interaction sits for chromatographic applications. Materials Chemistry and Physics 89 (2005):228-237.
51. W. Prukała, K. Pypowski, I. Chrzaścik, and M. Kluska, Separation of biologically active isomers of (E)-N-meta- and paranitroazastilbenes by the HPLC technique. Journal of Liquid Chromatography & Related Technologies 31 (2008):578-585.
52. W. Prukała, D. Prukała, K. Pypowski, I. Chrzaścik, and M. Kluska, Chromatography of biologically active chlorides of (E)-N-o-(mor p-)chlorobenzyl-γ -azastilbenols-2_(3_ or 4_). Journal of Liquid Chromatography & Related Technologies 31 (2008):2612-2620.
53. M. Kluska, Some aspects of the analysis of biologically active organogermanium substances, Critical Reviews in Analytical Chemistry 38 (2008):85-93.
54. M. Kluska, K. Pypowski, I. Chrzaśscik, T. Koval, and N. Erchak, Separation and determination of chosen λ5-silanates by the isotachophoresis technique. Journal of Liquid Chromatography & Related Technologies 32 (2009):896-907.
55. R. Gadzała-Kopciuch and B. Buszewski, Comparative study of hydrophobicity of octadecyl and alkylamide bonded phases using the methylene selectivity. Journal of Separation Science 26 (2003):1273-1283.
56. M. Kluska, E. Liepinsh, K. Pypowski, and N. Erchak, Separation of azepinio-methyl derivatives of ES-silanates by the use of aryl stationary phases in high performance liquid chromatography. Journal of Liquid Chromatography & Related Technologies 31 (2008):675-682.
57. M. Kluska, Analytical techniques in determination of biologically active organosilicons of the ES-silanate group. Critical Reviews in Analytical Chemistry 38 (2008):216-226.
58. M. Kluska, K. Pypowski, I. Chrzaścik, R. Gadzała-Kopciuch, M. Michel, E. Liepinsh, and N. Erchak, High performance liquid chromatography of benzyl derivatives of ES-silanates. Journal of Liquid Chromatography & Related Technologies 31 (2008):1195-1203.
59. M. Kluska, E. Liepinsh, K. Pypowski, I. Chrzaścik, M. Michel, and N. Erchak, Separation of chosen derivatives of hoszczawasilanates with taking advantage of π-π interactions. Journal of Liquid Chromatography&Related Technologies 31 (2008): 2812-2820.
60. D. Prukała, I. Chrzaścik, W. Prukała, K. Pypowski, M. Szymalska and M. Kluska, Isotachophoresis of chosen biologically active (E)-azastilbenes. Journal of Liquid Chromatography & Related Technologies (2009), (in press).